cytidine has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, AT; Cher, GB; Hong, RL; Hong, WK; Huat, TE; Hui, EP; Juergens, R; Marur, S; Tsao, A | 1 |
| Matsunaga, H; Strong, LC | 1 |
1 trial(s) available for cytidine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cytidine; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2013 |
1 other study(ies) available for cytidine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
An inverse correlation (dose-response between 5-methyl-cytidine and the fate of spontaneous tumours in mice.
Topics: Animals; Cytidine; Dose-Response Relationship, Drug; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary | 1975 |